Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013.
Identifieur interne : 000144 ( Main/Exploration ); précédent : 000143; suivant : 000145Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013.
Auteurs : Viktor Dahl [Suède] ; Anders Tegnell [Suède] ; Anders Wallensten [Suède]Source :
- PloS one [ 1932-6203 ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
- épidémiologie : Allemagne, Maladies transmissibles, Suède.
- étiologie : Maladies transmissibles.
- Humains, Priorités en santé, Surveillance de la santé publique.
- Wicri :
English descriptors
- KwdEn :
- MESH :
- geographic , epidemiology : Germany, Sweden.
- epidemiology : Communicable Diseases.
- etiology : Communicable Diseases.
- Health Priorities, Humans, Outcome Assessment, Health Care, Public Health Surveillance.
Abstract
To establish strategic priorities for the Public Health Agency of Sweden we prioritized pathogens according to their public health relevance in Sweden in order to guide resource allocation. We then compared the outcome to ongoing surveillance. We used a modified prioritization method developed at the Robert Koch Institute in Germany. In a Delphi process experts scored pathogens according to ten variables. We ranked the pathogens according to the total score and divided them into four priority groups. We then compared the priority groups to self-reported time spent on surveillance by epidemiologists and ongoing programmes for surveillance through mandatory and/or voluntary notifications and for surveillance of typing results. 106 pathogens were scored. The result of the prioritization process was similar to the outcome of the prioritization in Germany. Common pathogens such as calicivirus and Influenza virus as well as blood-borne pathogens such as human immunodeficiency virus, hepatitis B and C virus, gastro-intestinal infections such as Campylobacter and Salmonella and vector-borne pathogens such as Borrelia were all in the highest priority group. 63% of time spent by epidemiologists on surveillance was spent on pathogens in the highest priority group and all pathogens in the highest priority group, except for Borrelia and varicella-zoster virus, were under surveillance through notifications. Ten pathogens in the highest priority group (Borrelia, calicivirus, Campylobacter, Echinococcus multilocularis, hepatitis C virus, HIV, respiratory syncytial virus, SARS- and MERS coronavirus, tick-borne encephalitis virus and varicella-zoster virus) did not have any surveillance of typing results. We will evaluate the possibilities of surveillance for the pathogens in the highest priority group where we currently do not have any ongoing surveillance and evaluate the need of surveillance for the pathogens from the low priority group where there is ongoing surveillance in order to focus our work on the pathogens with the highest relevance.
DOI: 10.1371/journal.pone.0136353
PubMed: 26397699
PubMed Central: PMC4580468
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013.</title><author><name sortKey="Dahl, Viktor" sort="Dahl, Viktor" uniqKey="Dahl V" first="Viktor" last="Dahl">Viktor Dahl</name><affiliation wicri:level="3"><nlm:affiliation>The Public Health Agency of Sweden, Stockholm, Sweden; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>The Public Health Agency of Sweden, Stockholm, Sweden; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author><author><name sortKey="Tegnell, Anders" sort="Tegnell, Anders" uniqKey="Tegnell A" first="Anders" last="Tegnell">Anders Tegnell</name><affiliation wicri:level="3"><nlm:affiliation>The Public Health Agency of Sweden, Stockholm, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>The Public Health Agency of Sweden, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author><author><name sortKey="Wallensten, Anders" sort="Wallensten, Anders" uniqKey="Wallensten A" first="Anders" last="Wallensten">Anders Wallensten</name><affiliation wicri:level="4"><nlm:affiliation>The Public Health Agency of Sweden, Stockholm, Sweden; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>The Public Health Agency of Sweden, Stockholm, Sweden; Department of Medical Sciences, Uppsala University, Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26397699</idno><idno type="pmid">26397699</idno><idno type="doi">10.1371/journal.pone.0136353</idno><idno type="pmc">PMC4580468</idno><idno type="wicri:Area/Main/Corpus">000116</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000116</idno><idno type="wicri:Area/Main/Curation">000116</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000116</idno><idno type="wicri:Area/Main/Exploration">000116</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013.</title><author><name sortKey="Dahl, Viktor" sort="Dahl, Viktor" uniqKey="Dahl V" first="Viktor" last="Dahl">Viktor Dahl</name><affiliation wicri:level="3"><nlm:affiliation>The Public Health Agency of Sweden, Stockholm, Sweden; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>The Public Health Agency of Sweden, Stockholm, Sweden; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author><author><name sortKey="Tegnell, Anders" sort="Tegnell, Anders" uniqKey="Tegnell A" first="Anders" last="Tegnell">Anders Tegnell</name><affiliation wicri:level="3"><nlm:affiliation>The Public Health Agency of Sweden, Stockholm, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>The Public Health Agency of Sweden, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author><author><name sortKey="Wallensten, Anders" sort="Wallensten, Anders" uniqKey="Wallensten A" first="Anders" last="Wallensten">Anders Wallensten</name><affiliation wicri:level="4"><nlm:affiliation>The Public Health Agency of Sweden, Stockholm, Sweden; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>The Public Health Agency of Sweden, Stockholm, Sweden; Department of Medical Sciences, Uppsala University, Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communicable Diseases (epidemiology)</term><term>Communicable Diseases (etiology)</term><term>Germany (epidemiology)</term><term>Health Priorities (MeSH)</term><term>Humans (MeSH)</term><term>Outcome Assessment, Health Care (MeSH)</term><term>Public Health Surveillance (MeSH)</term><term>Sweden (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Allemagne (épidémiologie)</term><term>Humains (MeSH)</term><term>Maladies transmissibles (épidémiologie)</term><term>Maladies transmissibles (étiologie)</term><term>Priorités en santé (MeSH)</term><term>Surveillance de la santé publique (MeSH)</term><term>Suède (épidémiologie)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term><term>Sweden</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Communicable Diseases</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Communicable Diseases</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term><term>Maladies transmissibles</term><term>Suède</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Maladies transmissibles</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Health Priorities</term><term>Humans</term><term>Outcome Assessment, Health Care</term><term>Public Health Surveillance</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Priorités en santé</term><term>Surveillance de la santé publique</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term><term>Suède</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To establish strategic priorities for the Public Health Agency of Sweden we prioritized pathogens according to their public health relevance in Sweden in order to guide resource allocation. We then compared the outcome to ongoing surveillance. We used a modified prioritization method developed at the Robert Koch Institute in Germany. In a Delphi process experts scored pathogens according to ten variables. We ranked the pathogens according to the total score and divided them into four priority groups. We then compared the priority groups to self-reported time spent on surveillance by epidemiologists and ongoing programmes for surveillance through mandatory and/or voluntary notifications and for surveillance of typing results. 106 pathogens were scored. The result of the prioritization process was similar to the outcome of the prioritization in Germany. Common pathogens such as calicivirus and Influenza virus as well as blood-borne pathogens such as human immunodeficiency virus, hepatitis B and C virus, gastro-intestinal infections such as Campylobacter and Salmonella and vector-borne pathogens such as Borrelia were all in the highest priority group. 63% of time spent by epidemiologists on surveillance was spent on pathogens in the highest priority group and all pathogens in the highest priority group, except for Borrelia and varicella-zoster virus, were under surveillance through notifications. Ten pathogens in the highest priority group (Borrelia, calicivirus, Campylobacter, Echinococcus multilocularis, hepatitis C virus, HIV, respiratory syncytial virus, SARS- and MERS coronavirus, tick-borne encephalitis virus and varicella-zoster virus) did not have any surveillance of typing results. We will evaluate the possibilities of surveillance for the pathogens in the highest priority group where we currently do not have any ongoing surveillance and evaluate the need of surveillance for the pathogens from the low priority group where there is ongoing surveillance in order to focus our work on the pathogens with the highest relevance. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26397699</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013.</ArticleTitle><Pagination><MedlinePgn>e0136353</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0136353</ELocationID><Abstract><AbstractText>To establish strategic priorities for the Public Health Agency of Sweden we prioritized pathogens according to their public health relevance in Sweden in order to guide resource allocation. We then compared the outcome to ongoing surveillance. We used a modified prioritization method developed at the Robert Koch Institute in Germany. In a Delphi process experts scored pathogens according to ten variables. We ranked the pathogens according to the total score and divided them into four priority groups. We then compared the priority groups to self-reported time spent on surveillance by epidemiologists and ongoing programmes for surveillance through mandatory and/or voluntary notifications and for surveillance of typing results. 106 pathogens were scored. The result of the prioritization process was similar to the outcome of the prioritization in Germany. Common pathogens such as calicivirus and Influenza virus as well as blood-borne pathogens such as human immunodeficiency virus, hepatitis B and C virus, gastro-intestinal infections such as Campylobacter and Salmonella and vector-borne pathogens such as Borrelia were all in the highest priority group. 63% of time spent by epidemiologists on surveillance was spent on pathogens in the highest priority group and all pathogens in the highest priority group, except for Borrelia and varicella-zoster virus, were under surveillance through notifications. Ten pathogens in the highest priority group (Borrelia, calicivirus, Campylobacter, Echinococcus multilocularis, hepatitis C virus, HIV, respiratory syncytial virus, SARS- and MERS coronavirus, tick-borne encephalitis virus and varicella-zoster virus) did not have any surveillance of typing results. We will evaluate the possibilities of surveillance for the pathogens in the highest priority group where we currently do not have any ongoing surveillance and evaluate the need of surveillance for the pathogens from the low priority group where there is ongoing surveillance in order to focus our work on the pathogens with the highest relevance. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dahl</LastName><ForeName>Viktor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>The Public Health Agency of Sweden, Stockholm, Sweden; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tegnell</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Public Health Agency of Sweden, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallensten</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Public Health Agency of Sweden, Stockholm, Sweden; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS One. 2017 Mar 16;12 (3):e0174491</RefSource><PMID Version="1">28301601</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006292" MajorTopicYN="N">Health Priorities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062486" MajorTopicYN="Y">Public Health Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>07</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26397699</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0136353</ArticleId><ArticleId IdType="pii">PONE-D-15-18368</ArticleId><ArticleId IdType="pmc">PMC4580468</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Milbank Q. 2003;81(3):363-88</Citation><ArticleIdList><ArticleId IdType="pubmed">12941000</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2008 Jul;9 Suppl 1:S22-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18578019</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(10):e25691</Citation><ArticleIdList><ArticleId IdType="pubmed">21991334</ArticleId></ArticleIdList></Reference><Reference><Citation>Asia Pac J Public Health. 2010 Jul;22(3):279-88</Citation><ArticleIdList><ArticleId IdType="pubmed">19666949</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Policy. 2004 Jul;69(1):1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15484602</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Health Serv Res. 2009;9:43</Citation><ArticleIdList><ArticleId IdType="pubmed">19265518</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Infect Dis. 2000 Jan;11(1):21-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18159260</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Res Policy Syst. 2010 Dec 15;8:36</Citation><ArticleIdList><ArticleId IdType="pubmed">21159163</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Health Serv Res. 2010;10:131</Citation><ArticleIdList><ArticleId IdType="pubmed">20482843</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2008 Oct 2;13(40). pii: 18996</Citation><ArticleIdList><ArticleId IdType="pubmed">18831949</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Parasitol. 2002 Oct;18(10):421-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12377584</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Suède</li></country><region><li>East Middle Sweden</li><li>Svealand</li></region><settlement><li>Stockholm</li><li>Uppsala</li></settlement><orgName><li>Université d'Uppsala</li></orgName></list><tree><country name="Suède"><region name="Svealand"><name sortKey="Dahl, Viktor" sort="Dahl, Viktor" uniqKey="Dahl V" first="Viktor" last="Dahl">Viktor Dahl</name></region><name sortKey="Tegnell, Anders" sort="Tegnell, Anders" uniqKey="Tegnell A" first="Anders" last="Tegnell">Anders Tegnell</name><name sortKey="Wallensten, Anders" sort="Wallensten, Anders" uniqKey="Wallensten A" first="Anders" last="Wallensten">Anders Wallensten</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000144 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000144 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26397699
|texte= Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26397699" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |